The United States Army Medical Research Institute of Chemical Defense (USAMRICD) is the lead laboratory for medical chemical defense research for the Department of Defense and our nation.

The mission of the Institute includes the development of Bioscavengers against organophosphorus nerve agents.

In response to the Countermeasures Against Chemical Threats (CounterACT) program, sponsored by the National Institute of Neurological Disorders and Stroke (NINDS), the USAMRICD, in collaboration with five partner institutions, was awarded a Center of Excellence Grant to develop catalytic bioscavengers to protect civilian populations from chemical threat agents.